secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elicio Therapeutics, Inc. (ELTX)
CIK:        0001601485
Form:       8-K
Filed at:   2025-05-20T23:59:59+00:00
Accession:  0001601485-25-000076
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Elicio Therapeutics stockholders elect two directors, ratify auditor at annual meeting
--------------------------------------------------------------------------------

- Karen J. Wilson elected with 8,588,077 votes for, 420,412 against; 2,154,961 broker non-votes.
- Robert R. Ruffolo Jr. elected with 8,980,091 votes for, 28,388 against; 2,154,961 broker non-votes.
- Baker Tilly US, LLP ratified as auditor for FY2025 with 11,133,552 votes for, 29,923 against.
- Quorum of 70.1% achieved with 11,172,771 shares voted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601485/000160148525000076/0001601485-25-000076-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601485/000160148525000076/angn-20250519.htm
  HTML page:      https://secwatch.observer/filing/0001601485-25-000076

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer